Found 432 matching trials
Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease PHASE4 Cirrhosis is a form of advanced liver disease that can lead to serious comp...
Show More Location
Cleveland Clinic Main Campus
Learn More & Join Trial
Optimal Surveillance Strategy After Positive FIT and Negative Colonoscopy N/A Individuals with high fecal hemoglobin concentrations detected by fecal imm...
Show More Status
Enrolling By Invitation
Location
National Taiwan University Hospital
Learn More & Join Trial
A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer NA This study serves, in part, to prepare for a future large cohort study. The...
Show More Location
University Hospital Antwerp
Learn More & Join Trial
Xpert Bladder Cancer Monitor; Prospective, Single, Tertiary-care Center Implementation Study NA The primary objective of this prospective, single-centre study is to establ...
Show More Location
Urology and Nephrology Center
Learn More & Join Trial
Acute Posttraumatic Osteomyelitis in Patients With High-energy Tibial Fractures and Biomarkers N/A The present trial was aimed to identify which biomarkers could be associate...
Show More Location
Multiple Locations
Learn More & Join Trial
Amlodipine 10mg Drug Use Investigation N/A In this survey, to collect the safety and efficacy information in the subje...
Show More Location
Multiple Locations
Learn More & Join Trial
Korea Comirnaty Post-marketing Surveillance N/A This study will collect information on the safety of BNT162b2 products for ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treated With REVLIMID®, After Approval of Marketing Authorization for New Drug in Korea N/A The main purpose of REVLIMID® DUE (Drug Use Examination) is to collect and ...
Show More Location
Hallym University Sacred Heart Hospital
Learn More & Join Trial
Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced ESCC PHASE2 Tislelizumab combined with chemotherapy sequential neoadjuvant therapy for ...
Show More Status
Active Not Recruiting
Location
Sichuan Cancer Hospital and Research Institute
Learn More & Join Trial
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) PHASE1 This is a study to investigate the potential clinical benefit of trilacicli...
Show More Location
Genesis Cancer Center
Learn More & Join Trial